Cardiotoxicity and BTK Inhibitors - HealthTree for Chronic Lymphocytic Leukemia
[logo] HealthTree Foundation
search more_vert
close
person Sign In / Create Account

Cardiotoxicity and BTK Inhibitors: What CLL Patients Should Know

Cardiotoxicity and BTK Inhibitors: What CLL Patients Should Know  image

Cardiotoxicity and BTK Inhibitors: What CLL Patients Should Know

event Apr 16, 2025 / 05:00PM - 06:00PM EDT
link icon facebook logo X logo linkedin logo reddit logo email icon
videocam
Can't make it to the event?
We send a recording to all registered participants of the event!

Event Description

Dr. Kerry Rogers will be speaking to the HealthTree Chronic Lymphocytic Leukemia community about BTK Inhibitors and their cardiotoxicity. Join us for this webinar to learn more about this important topic!

 

Schedule & Agenda

The panelist Kerry Rogers, MD
5:05 PM
Presentation
Kerry Rogers, MD

Dr. Rogers talks about BTK Inhibitors and their cardiotoxicity.

The panelist Audience
5:35 PM
Questions and Answers
Audience

Type your questions in the chat, we will answer them!

The panelist Dalton Bean
5:00 PM
Introduction
Dalton Bean

Dalton introduces the agenda of the event and featured speaker Dr. Kerry Rogers

Speakers & Moderators

The panelist Dalton Bean
Dalton Bean
Lehi, UT

Dalton joined HealthTree in 2024 as the CLL and MF Education Manager. He is passionate about helping patients gain a better understanding of their health and treatment and sees it as a way to help empower individuals and their families who are affected by these diseases. Prior to joining HealthTree Dalton earned a Master’s Degree in Oncological Sciences while studying various different blood cancers. When not interacting with patients he is an avid snowboarder and hiker.

Read Bio
The panelist Kerry Rogers, MD
Kerry Rogers, MD

Dr. Kerry Rogers is a hematologist-oncologist dedicated to advancing the care and treatment of patients with chronic lymphocytic leukemia (CLL) and autoimmune cytopenias. Following her initial medical education at Chicago Medical School, she completed her residency in internal medicine at the University of Michigan. She then undertook fellowship at The Ohio State University in hematology and oncology, and after completion of her training, she was delighted to join the staff at the OSUCCC – James. In addition to clinical work, she spends time teaching medical students and resident physicians as an assistant professor in the Department of Hematology. As a member of the Leukemia Research Program at the OSUCCC – James, she conducts research in the Experimental Hematology Laboratory developing novel therapeutics for autoimmune cytopenias. Her research group has an interest in finding optimal strategies for the use of BTK inhibitors, including studying resistance, combination therapies and treatment discontinuation. She is currently the principal investigator on four open and two pending clinical trials in this area, including two investigator-sponsored trials and an NCI study. She has also written several articles for publication in medical journals such as Leukemia and Cancer Cell, and has prepared numerous abstracts and posters for presentations. What she loves most about The James is working with very passionate and committed team members to give patients the very best care. She feels that communication is a key aspect to providing the best medical care and enjoys spending time with her patients most of all.

Read Bio
HealthTree Connect Icon

Join the Conversation

This event is part of the Newly Diagnosed group in HealthTree Connect, a social media platform for people with blood cancer. If you want to connect with other patients and caregivers and talk about this topic, join HealthTree Connect.

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

All HealthTree resources available anywhere, anytime
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Chronic Lymphocytic Leukemia Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.

Thanks to our HealthTree Community for Chronic Lymphocytic Leukemia Sponsors:

Abbvie